EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell functionYusuke Isshiki(Cornell University), Wendy Béguelin(Cornell University)Cancer CellDecember 5, 202410.1016/j.ccell.2024.11.006Cited by 55SaveCiteExport RISWatch citationsRelated PapersEZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models|Cancer Cell|2025|47